Clinical impact of hematogones on outcomes of allogeneic hematopoietic stem cell transplantation

Annals of Hematology
Noriko DokiKazuteru Ohashi

Abstract

Increased levels of normal B cell precursors, termed hematogones (HGs), are observed in regenerating bone marrow after chemotherapy or hematopoietic stem cell transplantation (HSCT). Recent reports suggest that emergence of HGs is associated with better outcomes following allogeneic HSCT (allo-HSCT). We reviewed the emergence of HGs and the clinical features of 192 patients after allo-BMT. Patients undergoing allo-BMT from related donors were more likely to develop HGs at day 30 compared to unrelated donors. Furthermore, patients undergoing allo-BMT from HLA-mismatched donors were less likely to develop HGs at day 30. The emergence of HGs at day 30 was an independent prognostic factor among patients who underwent BMT. We found no difference in the relapse rate between HG-positive (+) and HG-negative (-) patients undergoing BMT. HG (-) patients had high non-relapse mortality, grade II to IV acute graft-versus-host-disease (GVHD), fungal infection, and lower IgG levels compared to HG (+) patients. The emergence of HGs at day 30 among patients undergoing BMT may be a very useful indicator of subsequent survival outcomes or acute GVHD in common clinical practice.

References

Sep 13, 1990·The New England Journal of Medicine·K M SullivanR P Witherspoon
Dec 14, 1999·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·L C FeinsteinK M Sullivan
May 3, 2008·Leukemia & Lymphoma·Ol'ga BabusíkováEsko Kankuri
Sep 15, 2009·Blood·Alexander Shimabukuro-VornhagenMichael S von Bergwelt-Baildon
Dec 17, 2009·Leukemia & Lymphoma·Deborah W SevillaBachir Alobeid
Nov 17, 2010·Blood·Sylvain P ChantepieOumedaly Reman
May 17, 2011·Bone Marrow Transplantation·J Gregoire-GauthierE Haddad
Nov 24, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Theodore HonebrinkMichael R Verneris
Aug 13, 2013·Leukemia Research·S P ChantepieO Reman

❮ Previous
Next ❯

Citations

Jun 18, 2018·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Takashi IshioTakanori Teshima
Apr 28, 2021·Cytometry. Part B, Clinical Cytometry·Mesut Göçer, Erdal Kurtoğlu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.